Article
Performance and considerations in the use of diagnostic mutation panels for clonality testing in non-small-cell lung carcinoma
1 May 2025
Abstract excerpt
INTRODUCTION: Next-generation sequencing (NGS) mutation panels are widely implemented and commonly applied to aid clonality classification for non-small-cell lung carcinoma (NSCLC) patients with multiple tumors. Performance of different NGS panels for clonality classification, however, remains unresolved. METHODS: We assembled 210 primary and metastatic pairs from lung adenocarcinoma (LUAD) and lung squamous-cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
